Individuals Discontinuing Anti-Obesity Medications Regain Pounds Four Times Faster Compared to Dieters

Fresh analysis indicates that people who come off popular GLP-1 drugs like Wegovy and Mounjaro may regain lost weight at a significantly accelerated pace than those who end traditional diet and exercise regimens.

Research printed in a prominent health publication demonstrates that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying these treatments need to be informed of the danger of quick weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

This pace of regain suggests a return to starting mass within about 18 months.

Comparing Treatments

The research, which examined dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with other pills.

Scientists point out that people who lose weight through lifestyle changes alone usually experience a more gradual creep back—perhaps 0.1 kg a month—once they finish.

The Reason for the Fast Regain

Nutrition scientists believe the mode of action of the jabs is key to understanding the accelerated rebound.

The injections imitate a body's own chemical called GLP-1, which moderates appetite.

"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this GLP-1 'fix' results in appetite is uncontrolled, making excessive eating far more likely."

An Ongoing Disease?

Health authorities recommend the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Many experts argue that, given the significant potential of weight regain, the treatment might need to be long-term.

This view is echoed by pharmaceutical companies, who say that the results "highlight the long-term nature of excess weight," akin to managing conditions like high blood pressure.

User Accounts

People who have stopped the jabs report a powerful return of hunger.

"It was like a trigger flipping and you become extremely hungry," recalled an individual.

The struggle is compounded if individuals have not established permanent dietary or behavioural modifications during treatment.

Growing Use

Figures indicate that millions of people in the UK have tried these injections in the past year, with desire being substantial.

• Adoption is higher among women than men.
• The 40s and 50s age group shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

Finally, clinicians emphasize that while these medications are potent tools for weight loss, they are not a magic fix and lasting health benefits relies on combined behavioural management.